# Ozempic vs Rybelsus: Dosage, Uses and Side Effects

Source: https://pepvault.app/drugs/compare/ozempic-vs-rybelsus

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Brand-name drugs](https://pepvault.app/drugs) Ozempic vs Rybelsus

Same ingredient, two names · semaglutide

# Ozempic vs Rybelsus

From the two FDA labels, read Nov 18, 2026 [Published by PepVault](https://pepvault.app/guides/how-we-research)

Ozempic and Rybelsus are the same medicine, semaglutide, under two names from Novo Nordisk.

What differs is the label. FDA approved Ozempic for blood sugar control in adults with type 2 diabetes, and lowering heart and kidney risks in some of them. Rybelsus is approved for blood sugar control in adults with type 2 diabetes, and lowering heart risk in those at high risk.

## Label against label

Ozempic and Rybelsus, from their FDA labels and Drugs@FDA

| Compared | [Ozempic](https://pepvault.app/drugs/ozempic) | [Rybelsus](https://pepvault.app/drugs/rybelsus) |
| --- | --- | --- |
| Active ingredient | semaglutide | semaglutide |
| Class | GLP-1 receptor agonist | GLP-1 receptor agonist |
| Maker | Novo Nordisk | Novo Nordisk |
| Approved for | Type 2 diabetes; heart and kidney risk in type 2 diabetes | Type 2 diabetes; heart risk in type 2 diabetes |
| Forms | Multi-dose pen; Single-dose prefilled syringe; Tablet | Tablet |
| How often | once a week or once a day | once a day |
| Starting dose | 0.25 mg a week (injection); 1.5 mg a day (tablets) | 3 mg a day |
| Top dose on the label | 2 mg a week (injection); 9 mg a day (tablets) | 14 mg a day |
| Most reported side effect | Nausea, 20.3% on 1 mg (placebo 6.1%) | Nausea, 20% on 14 mg (placebo 6%) |
| Boxed warning | “RISK OF THYROID C-CELL TUMORS” | “RISK OF THYROID C-CELL TUMORS” |
| First approved | 2017 | 2019 |

Each label’s side-effect figure comes from its own trials, at its own doses and in its own patients; as the labels themselves say, rates from different trials can’t be compared directly.

## The two dosing schedules

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

### Ozempic injection, once a week

Ozempic’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

### Ozempic tablets, once a day

Ozempic’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

### Rybelsus, once a day

Rybelsus’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-vs-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## A missed dose, on each label

- [Ozempic](https://pepvault.app/drugs/ozempic): A missed weekly injection is taken as soon as possible within 5 days. Past 5 days, the label skips it and the next dose comes on the usual day.
- [Rybelsus](https://pepvault.app/drugs/rybelsus): There is no catching up on Rybelsus: the label says a forgotten tablet is skipped and the next one taken the day after.

## The research on the ingredient

- [Semaglutide in the peptide library: the research on the one ingredient](https://pepvault.app/peptides/semaglutide)
- [Ozempic: the label in full](https://pepvault.app/drugs/ozempic)
- [Rybelsus: the label in full](https://pepvault.app/drugs/rybelsus)

## Questions

### Are Ozempic and Rybelsus the same drug?

They hold the same active ingredient, semaglutide, from Novo Nordisk. They are approved for different uses and come in different forms and doses.

### What are Ozempic and Rybelsus approved for?

Ozempic is approved for blood sugar control in adults with type 2 diabetes, and lowering heart and kidney risks in some of them. Rybelsus is approved for blood sugar control in adults with type 2 diabetes, and lowering heart risk in those at high risk.

### How often are Ozempic and Rybelsus taken?

Ozempic is taken once a week or once a day, as an injection or a tablet; Rybelsus once a day, as a tablet.

### What are the dose ranges of Ozempic and Rybelsus?

On their labels, Ozempic runs 0.25 mg to 2 mg once a week or 1.5 mg to 9 mg once a day, and Rybelsus 3 mg to 14 mg once a day. A prescriber sets the actual dose.

### What is the most common side effect of Ozempic and Rybelsus?

On Ozempic’s label: nausea, 20.3% on 1 mg (placebo 6.1%). On Rybelsus’s: nausea, 20% on 14 mg (placebo 6%).

## Sources

- [OZEMPIC (semaglutide) injection, for subcutaneous use, FDA label on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79) (version 20, published Jun 10, 2026; read Nov 18, 2026)
- [RYBELSUS (semaglutide) tablets and OZEMPIC (semaglutide) tablets, for oral use, FDA label on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98) (version 14, published Aug 19, 2026; read Nov 18, 2026)
- [Drugs@FDA, NDA 209637](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209637) (Ozempic, the injection; application first approved 2017)
- [Drugs@FDA, NDA 213051](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213051) (Ozempic, the tablets, added to the application by supplement 30 on Jan 30, 2026; application first approved 2019)
- [Drugs@FDA, NDA 213051](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213051) (Rybelsus, the tablets; application first approved 2019)

PepVault is not affiliated with Novo Nordisk. Ozempic is a trademark of its owner. Rybelsus is a trademark of its owner.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-vs-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-vs-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## On the two labels

### Read further

- [Semaglutide in the peptide library: the research on the one ingredient](https://pepvault.app/peptides/semaglutide)
- [Ozempic: the label in full](https://pepvault.app/drugs/ozempic)
- [Rybelsus: the label in full](https://pepvault.app/drugs/rybelsus)

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-vs-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Brand-name drugs

- [Every brand, by ingredient](https://pepvault.app/drugs)
- [Ozempic](https://pepvault.app/drugs/ozempic)
- [Rybelsus](https://pepvault.app/drugs/rybelsus)

## More pairs

- [Ozempic vs Wegovy](https://pepvault.app/drugs/compare/ozempic-vs-wegovy)
- [Ozempic vs Mounjaro](https://pepvault.app/drugs/compare/ozempic-vs-mounjaro)
- [Ozempic vs Zepbound](https://pepvault.app/drugs/compare/ozempic-vs-zepbound)
- [Ozempic vs Victoza](https://pepvault.app/drugs/compare/ozempic-vs-victoza)
- [Ozempic vs Trulicity](https://pepvault.app/drugs/compare/ozempic-vs-trulicity)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. PepVault is not affiliated with Novo Nordisk. Ozempic is a trademark of its owner. Rybelsus is a trademark of its owner.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
